Ryan E. Wiegand, PhD; et al., Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design (2026) is a certified entry in Truverai's communication library, filed as a communication of 5198 words. Its composite score is 93 out of 100.
From the communication: Original Investigation | Infectious Diseases Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design Ryan E. Wiegand, PhD; Sean Chickery, DHSc; Duck-Hye Y
Ryan E. Wiegand, PhD; et al.'s text was scored under the same locked configuration as every other entry in the library, which is what makes the 93 comparable to the rest. Truverai measures how a communication is presented, not whether the speaker was right, and it scores what was said rather than who said it.
This page needs JavaScript for the full interactive view. The summary above is the same information in plain HTML.